Your Tech Transfer Office as a Chief Navigation Office: Guiding Innovation from Lab to Impact
As life sciences transactions grow more data-drive and partnership-oriented, the role of the Technology Transfer Office (TTO) is shifting. This session examines how forward-thinking offices are acting as Chief Navigation Offices to help guide inventors, startups, and industry partners through IP strategy, data and AI considerations, federal reporting requirements, and complex deal structures. Designed for entrepreneurs, corporate alliance professionals, and ecosystem leaders, the discussion will highlight how research institutions help translate discovery into scalable products, partnerships, and commercial impact.
- Zev Sunleaf, VP, Technology Transfer & Commercialization (Moderator), Children’s Hospital of Philadelphia
- Adam Van Dyke, PhD, AVP, Innovation & Translational Development, Fox Chase Cancer Center
- Justin Crotty, PhD, JD, Partner, Saul Ewing LLP
- Greg Jackson, PhD, Executive Vice President, Life Sciences Greenhouse Investments